[Federal Register Volume 64, Number 248 (Tuesday, December 28, 1999)] [Notices] [Pages 72685-72686] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 99-33650] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on October 21, 1999, Medeva Pharmaceuticals CA, Inc., 3501 West Garry Avenue, Santa Ana, California 92704, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Methylphenidate (1724).................... II [[Page 72686]] Diphenoxylate (9170)...................... II ------------------------------------------------------------------------ The firm plans to manufacture the listed controlled substances to make finished dosage forms for distribution to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration. Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than February 28, 2000. Dated: December 16, 1999. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 99-33650 Filed 12-27-99; 8:45 am] BILLING CODE 4410-09-M